WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006019906) Biomarker for early detection of ovarian cancer
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/019906    International Application No.:    PCT/US2005/024985
Publication Date: 23.02.2006 International Filing Date: 14.07.2005
IPC:
G01N 33/72 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; 1111 Franklin Street, 12th Floor, Oakland, CA 94607 (US) (For All Designated States Except US).
FARIAS-EISNER, Robin [US/US]; (US) (For US Only).
REDDY, Srinivasa, T. [US/US]; (US) (For US Only)
Inventors: FARIAS-EISNER, Robin; (US).
REDDY, Srinivasa, T.; (US)
Agent: CANADY, Karen, S.; Gates & Cooper LLP, 6701 Center Drive West, Suite 1050, Los Angeles, CA 90045 (US)
Priority Data:
60/588,007 14.07.2004 US
60/674,489 25.04.2005 US
Title (EN) Biomarker for early detection of ovarian cancer
(FR) BIOMARQUEUR POUR DETECTER DE MANIERE PRECOCE UN CANCER DES OVAIRES
Abstract: front page image
(EN)Biomarker proteins that can be used in the diagnosis of early-stage ovarian cancer (OC) are described. The biomarker panels not only permit the distinction of patients with ovarian neoplasia (benign or malignant) from normal subjects, but they also allow the identification of patients with early-stage (stage I/II) ovarian cancer from those patients with benign ovarian tumors or normal individuals. The invention additionally provides methods for detecting and treating various cancers, including cancer of the ovary using OC-related molecules.
(FR)L'invention concerne des protéines biomarqueurs qui peuvent être utilisées dans le diagnostic d'un cancer ovarien précoce. Les panels de biomarqueurs permettent la distinction de patients présentant une néoplasie (bénigne ou maligne) des sujets normaux, et ils permettent également l'identification des patients présentant un cancer ovarien (étape I/II) précoce des patients présentant des tumeurs ovariennes bénignes ou des individus normaux. L'invention concerne également des procédés pour détecter et traiter de nombreux cancers, notamment le cancer des ovaires au moyen des molécules associées au cancer des ovaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)